Benchmark domestic stocks plunged around one and a half per cent in intra-day trade on Thursday, January 28, 2021, ahead of the monthly derivative contracts' expiry later in the day. At 12:58 pm, the BSE Sensex was trading 752.97 points or 1.59% down at 46,656.96. The NSE Nifty also declined 212.25 points or 1.52% down to trade at 13,755.25.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

HDFC Bank fell 4.25% and was the top loser on the Nifty 50 index and was followed by Wipro, Power Grid, Hindustan Unilever, and Kotak Mahindra Bank (all down more than 3%).On the other hand, Axis Bank was up 3.52% and was followed by Hero MotoCorp, BPCL, IOC and Tata Motors. Meanwhile, there are certain stocks which were in action in either direction based on reports linked to them. Here is a list of few such stocks:

Bharti Airtel (down 0.58%): The telecom major has tested 5G wireless service over the commercial network in Hyderabad. With this, it became India’s first telecom operator to conduct on-field rollout of the next-generation mobile technology. The telco will be able to roll out the services across several parts of the country as soon as the department of telecommunications permits the commercial launch of 5G and auctions spectrum in the mid-size bands.

Eris Lifesciences (up 2.42%): Announced financial results for the quarter ended December 31, 2020, and reported a profit of Rs 90 crore against Rs 63 crores reported last year in the same quarter. 

Prism Johnson (down 1.11%): Announced financial results for the quarter ended December 31, 2020, and reported a profit of Rs 47 crore against Rs 2.6 crore posted in the corresponding quarter last year.

See Zee Business Live TV Streaming Below:

Glenmark Pharmaceutical + Sun Pharmaceutical + Cadila

Glenmark Pharmaceutical (down 1.04%): Glenmark Pharmaceuticals receives ANDA approval for Amphetamine Sulfate Tablets USP, 5 mg and 10 mg.

Sun Pharmaceutical (down 1.03%): Taro Pharmaceuticals has announced its December quarter numbers and reported a decline in profit at $3.3 crore against $6.8 crore posted last year in the same quarter. Taro is a subsidiary of Sun Pharmaceuticals. 

Cadila (down 0.12%): Zydus granted Orphan Drug Designation by the USFDA for Saroglitazar in the treatment of patients with Primary Biliary Cholangitis (PBC).

IPO Update: 

Stove Kraft Ltd: The Rs 413 crore IPO of Stove Kraft Ltd, a manufacturer of kitchen appliances, was subscribed 5.29 times at 1:15 pm. The company has fixed a price band of Rs 384 to Rs 385 per equity share. The public issue will close today.